Madagascar – IP Case Study – Drug Patents and the Bolar Exemption in Madagascar

A pharmaceutical company A from the European Union operates in the industrial city of Ansirabe, Madagascar. Company A sought to obtain marketing approval for its own generic drug made from the active pharmaceutical ingredients, prior to the expiration of the drug patent. Company A’s decision was influenced by the Bolar exemption which its parent company in Europe has leveraged in their market strategy.